Gregory AustinUnclaimed
Host of BioTalk Unzipped.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where Gregory has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Gregory on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Gregory claims this profile.
Recommendations
No recommendations for Gregory yet.
Recommendations open once Gregory claims the profile.
Posts
No posts yet. Posts Gregory shares on PodSubs, and what Gregory publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Why Finding the Right Drug Dose Is So Difficult | Dr. Ewoud-Jan van Hoogdalem
A drug shows promise in a small patient study. How much does that tell you about the dose you should test next? Gregory Austin and Dr. Chad Briscoe explore that question with Dr. Ewoud-Jan van Hoogdalem, a...
Listen to the audio
Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge
Rob Dodge says AI has made him an expert Python programmer, even though he never took a class in it. But does having new capabilities change what it means to be a scientist? Dr. Chad Briscoe sits down with Dr. Robert...
Listen to the audio
Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White
Clinical trials often collect far more blood than an assay actually needs. Dr. Joleen White asks a more disciplined question: What information is required to make a sound decision, and how little sample can be collected...
Listen to the audio
Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey
Why is gene therapy still so difficult to manufacture at scale after decades of progress? Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversation about one of...
Listen to the audio
Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan
A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship. Sponsored by Leucentra, https://leucentra.com/...
Listen to the audio
The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi
Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement. Sponsored by Leucentra, https://leucentra.com/ Inspired by science, empowered by IT. Leucentra...
Listen to the audio
Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker
Can artificial intelligence help make cancer therapies safer, more targeted, and more effective? In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor at Duke...
Listen to the audio
Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains
Why haven’t we cured cancer yet? A Genentech scientist explains the real reason. In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Scientist at...
Listen to the audio
The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney
Recorded October 31, 2025 In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gerstein & Borun, to...
Listen to the audio
Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins
In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science and strategy behind...
Listen to the audio
